Collection of tissue, blood, and body fluid samples from patients with hematologic cancer
Official title: Tissue Procurement For Hematolymphoid Conditions
Run by UNC Lineberger Comprehensive Cancer Center · NCT01137643 · Data updated 2026-11-12
This study is collecting tissue, blood, and body fluid samples from patients with blood cancers to help improve cancer research and patient care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | July 2009 |
| Main results expected | July 2040 |
| Study ends | July 2040 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT01137643 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed with hematologic cancers such as leukemia, lymphoma, and multiple myeloma who are being evaluated at the University of North Carolina Hospitals.
✕Probably not a fit
Patients not diagnosed with hematologic cancers or those not receiving care at the specified clinics may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research involves collecting and storing samples of tissue, blood, and body fluids from patients diagnosed with various hematologic cancers. The samples will be used for ongoing diagnostic, prognostic, and immune-monitoring studies to enhance cancer research. The study aims to support both clinical and basic research efforts at the Lineberger Comprehensive Cancer Center and ensure responsible patient care and research conduct. Patients will undergo sample collection during routine diagnostic procedures, which may include biopsies and blood draws.
Why it matters
Potential benefit: If successful, this study could significantly advance the understanding and treatment of hematologic cancers.
How similar studies have gone: Other studies involving sample collection for cancer research have shown success in enhancing understanding and treatment options, making this approach well-supported by previous research.
Who can join: the full rules
Show full inclusion / exclusion criteria
DISEASE CHARACTERISTICS: * Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: * Acute myeloid leukemia * Acute lymphoblastic leukemia * Chronic myelogenous leukemia * Chronic lymphoid leukemia * Non-Hodgkin lymphoma * Hodgkin lymphoma * Myelodysplastic syndromes * Myeloproliferative disorders * Multiple myeloma * Waldenstrom macroglobulinemia * Aplastic anemia * Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage * Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified
Where it's running
-
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Paul Armistead, MD — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Paul Armistead, MD
- Email: paul_armistead@med.unc.edu
- Phone: (919) 843-6847
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry of older patients with cancer
This study collects health information from older cancer patients to create a registry that helps improve care and research for seniors with cancer.
-
Cord blood transplant for children and young adults with blood cancers.
This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.
-
Improving outcomes for stem cell transplant patients using an intervention website
This study is testing if a special website can help adults with blood cancer feel better and improve their quality of life after a stem cell transplant compared to a regular educational website.
-
Home blood transfusions for people with advanced blood cancers in hospice
The study will test whether offering home blood transfusions to adults with advanced or relapsed blood cancers who are eligible for hospice helps improve quality of life, mood, and end-of-life care.
-
Impact of Leukemia and Lymphoma Society services on blood cancer patients
This study is testing how the services provided by the Leukemia and Lymphoma Society can help people with blood cancers feel better and manage their care over six months.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.